New Brunswick-based Johnson & Johnson announced Tuesday sales of $18.1 billion for the first quarter of 2014, an increase of 3.5 percent compared to the first quarter in 2013.
According to the announcement, operational results increased 5.3 percent, domestic sales increased 2.2 percent and international sales increased 4.5 percent. Net earnings and diluted earnings per share for the quarter were $4.7 billion and $1.64 billion, respectively.
"Johnson & Johnson delivered strong first-quarter results driven by successful new product launches and the continued growth of key products," said Alex Gorsky, chairman and chief executive officer. "Our talented colleagues around the world continue to bring meaningful innovations to patients and customers, addressing significant unmet needs. We also advanced our near-term priorities and long-term growth drivers, positioning us well to deliver sustainable results."
To see the full report, click here.
ALSO ON NJBIZ: